NCT01324856

Brief Summary

Pancreaticoduodenectomy is the standards surgical procedure for various malignant and benign disease of the pancreas and periampullariy region. During the recent years, mortality rate of pancreaticoduodenectomy has decreased to 5% in specialized centers. Although, this procedure still carries considerable morbidity up to 40%, depending of definition of complications. Pancreatic fistula remains a common complication and the main cause of other morbidities and mortality. Pancreaticojejunal (PJ) anastomosis is the most often used method of reconstruction after pancreaticoduodenectomy. Several technique modifications such as placement of the stents, reinforcement of anasomosis with fibrin glue, pancreatic duct occlusion and pancreaticogastrostomy (PG) type of anastomosis was used in order to decrease pancreatic fistula rate. Since, some retrospective studies showed better results with some technique, several meta-analyses did not show any advantage of those various modifications. It was shown that the higher risk of pancreatic fistula was noticed in patients with soft residual pancreas and small diameter of pancreatic duct. There is only one randomized study in the literature dealing with this problem. This study did not reveal any significant differences between PG and PJ in patients with soft pancreas and small duct. In order to investigate once more this important issue, the researchers conducted randomized multicenter controlled trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for phase_1 pancreatic-cancer

Timeline
Completed

Started Apr 2011

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 29, 2011

Completed
3 days until next milestone

Study Start

First participant enrolled

April 1, 2011

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

April 11, 2011

Status Verified

February 1, 2011

Enrollment Period

2 years

First QC Date

March 28, 2011

Last Update Submit

April 8, 2011

Conditions

Keywords

pancreatic cancerperiampulary cancerpancreaticogastro vs pancreaticojejuno anastomosis

Outcome Measures

Primary Outcomes (1)

  • abdominal complications

    Abdominal complications comprises: Pancreatic fistula, acute fluid collection, acute pancreatitis, billiay fistula, gastric fistula, enteral distula, hemorrhage and delayed gastric emptying

    2 years

Study Arms (2)

Pancreaticogastro anastomosis

EXPERIMENTAL
Procedure: Pancreatico gastro anastomosis

Pancreaticojejuno anastomosis

ACTIVE COMPARATOR
Procedure: Pancreaticojejuno anastomosis

Interventions

After the pylorus preserving cephalic pancreaticoduodenectomy, pancreatico gasto teremino-lateral anastomosis will be performed. The anastomosis will be done with posterior wall of the stomach. Pancreas will be mobilized at least 5 cm, two tobaco stiches will be applied on posterior wall of the stomach and hole of 2 cm will be done in the middle. Anterior wall of the stomach will be opened, for easier placement of the pancreas in to the stomach cavity. Pancreas will be entered in the stomach trough , tobacco stitches tided and just 2 or 3 stitches will be applied on the stomach mucosa and pancreatic capsule. After that classic hepatico jejuno and antecolic duodeno jejuno anatomosis will ber performed.

Pancreaticogastro anastomosis

After the pylorus preserving cephalic pancreaticoduodenectomy, pancreatico jejuno termino lateral duct to mucosa anastomosis will be performed. After that classic hepatico jejuno and antecolic duodeno jejuno anatomosis will ber performed.

Pancreaticojejuno anastomosis

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergone cephalic duodenopanceatectomy
  • soft pancreas
  • small diameter of the pancreatic remnant

You may not qualify if:

  • Age bellow 18 and under 80
  • prevous pancreatic surgery
  • pregnancy
  • Psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Clinic for Digestive Surgery, Clinical Center of Serbia and School of Medicine University of Belgrade

Belgrade, 11000, Serbia

Location

Clinic for Emergency Surgery, Clinical Center of Serbia and School of Medicine, University of Belgrade

Belgrade, 11000, Serbia

Location

Surgical Department, Clinical Center "Bezanijska Kosa" and School of Medicine, University of Belgrade

Belgrade, 11000, Serbia

Location

Surgical Department, Military-Medical Academy

Belgrade, 11000, Serbia

Location

Related Publications (3)

  • Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, Buchler MW. Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg. 2007 Feb;193(2):171-83. doi: 10.1016/j.amjsurg.2006.10.010.

    PMID: 17236843BACKGROUND
  • Bassi C, Falconi M, Molinari E, Salvia R, Butturini G, Sartori N, Mantovani W, Pederzoli P. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. Ann Surg. 2005 Dec;242(6):767-71, discussion 771-3. doi: 10.1097/01.sla.0000189124.47589.6d.

    PMID: 16327486BACKGROUND
  • Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, Lillemoe KD, Pitt HA. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995 Oct;222(4):580-8; discussion 588-92. doi: 10.1097/00000658-199510000-00014.

    PMID: 7574936BACKGROUND

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Dejan Radenkovic, MD,PhD

    Clinic for Digestive disease, Clinical center of Serbia and School of Medicine University of Belgrade

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dejan Radenkovic, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 28, 2011

First Posted

March 29, 2011

Study Start

April 1, 2011

Primary Completion

April 1, 2013

Study Completion

September 1, 2013

Last Updated

April 11, 2011

Record last verified: 2011-02

Locations